ORBIMED ADVISORS LLC

Q4 2022 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
12/31/2022
Date filed
2/14/2023
Form type
13F-HR
Num holdings
116
Total value ($000)
$5,227,458
Net value change ($000)
-159,542 (-3.0%)
New positions
8
Sold out positions
22
Turnover %
9.9%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q3 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
UNH 66,786 49.5%
CMPX 62,414 124.7%
VRNA 61,273 105.3%
ISRG 57,303 53.4%
PCVX 44,296 257.1%
IRON 42,981 NEW
IONS 41,290 121.4%
TERN 33,499 76.0%
SYK 31,905 37.2%
BSX 29,393 19.5%
Top Reduces (Value $000, Stocks/ETFs)
Tricida, Inc. -107,744 -100.0%
ARGX -89,081 -93.6%
Third Harmonic Bio, Inc. -84,779 -77.3%
ABBV -80,526 -100.0%
GH -53,421 -100.0%
ALNY -50,140 -100.0%
PFE -42,324 -37.2%
Mirati Therapeutics, Inc. -40,931 -41.3%
ACET -39,321 -37.1%
VRTX -29,652 -27.4%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 4,843 (0.1% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 ORBIMED CAPITAL LLC 028-10410